The APP-Tg group injected with NRG1 type III showed a trend of improvement compared with the APP-Tg controls.
← all excerpts
Neuregulin 1 improves cognitive deficits and neuropathology in an Alzheimer's disease model.
1
—
—
The APP-Tg group injected with NRG1 type III showed a trend of improvement compared with the APP-Tg controls.